Abu Dhabi Health Data Services (ADHDS), a component of M42’s Digital Health Solutions (DHS) platform, has announced a new collaboration with Syndesis Health. This partnership aims to advance artificial intelligence (AI)-driven genomic analytics and drug discovery. The collaboration is set to leverage Syndesis Health’s expertise in data science and analytics to provide enhanced genomic insights....
M42, AstraZeneca, and SOPHiA GENETICS have announced a new initiative to enhance cancer diagnosis and care in the United Arab Emirates through advanced liquid biopsy testing. This strategic collaboration aims to improve the accuracy of cancer diagnoses, inform treatment decisions, and facilitate real-time monitoring of disease progression in a manner that is both cost-effective and...
Abu Dhabi is planning to construct an advanced cancer treatment center, which will be the first of its kind in the Middle East. This initiative is part of a multibillion-dollar effort to diversify the emirate’s economy and enhance its healthcare sector. The facility will be developed through a partnership between M42’s Cleveland Clinic Abu Dhabi...
Healthpoint, a member of the M42 group, is improving its services in plastic and reconstructive surgery by treating specific chronic conditions including lymphedema and lipedema. Abnormal fat and fluid accumulation, which results in persistent swelling and discomfort, is a defining feature of many disorders. Modern artificial intelligence (AI) and technology will be used in the...
A significant partnership has emerged between M42, a global health technology leader, and the UAE’s Ministry of Defence (MoD). This collaboration was highlighted during a panel discussion at Sheikh Sultan bin Zayed (SSBZH) Hospital on the final day of Arab Health, titled “Innovative Integration: M42 and Zayed Military Hospital Pioneering Sheikh Sultan Bin Zayed Hospital...
An Emirati woman has successfully addressed a predisposition to cancer before it could develop, thanks to her participation in the UAE’s genome project. Healthcare group M42 officials revealed on the second day of Arab Health that they detected a gene mutation in her report, potentially leading to thyroid cancer. According to Khaleej Times, Hasan Jasem...